NCT06598449 - Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 22, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

July 31, 2027

Conditions

Dravet Syndrome (DS)Children Under 2 Years

Interventions

DRUG

fenfluramine

Clear, cherry flavored oral solution

Trial Locations (3)

NOT_YET_RECRUITING

Mayo Clinic, Rochester

RECRUITING

Children's Hospital Colorado, Aurora

NOT_YET_RECRUITING

University of California San Francisco, San Francisco